Respiratory Illness Protection
As the nation’s leading vaccine purchasing group, we pride ourselves in the high-quality support and resources we provide to our members. In response to the recent spike in respiratory illness–related hospitalizations nationwide, we have summarized the most critical disease and vaccine information providers should know to best protect their patients.
-
Atlantic Health Partners works directly with leading vaccine manufacturers to offer the favorable pricing, payment, and purchasing terms for an array of pediatric, adolescent, and adult vaccines. Once a physician practice or healthcare organization is linked to our national agreement platform, members can place orders directly with the manufacturers or eligible distributers and will automatically receive our preferred contracted pricing. Purchases can be made online, by phone, or directly with your representatives, and the manufacturers and distributers will then ship the vaccines directly to the practice.
Upcoming Webinars
Tune in to upcoming webinars from leading respiratory illness vaccine manufacturers. Save your spot to hear the latest updates, gain expert insights, and build your knowledge as you prepare for the upcoming immunization season.
Click the logos below to learn more about each manufacturer’s webinar and access the registration link.
GSK | 2025 ADULT RSV AWARENESS SERIES
Focused on the needs of healthcare professionals, this webinar series will feature GSK patient advocates an explore the burden of respiratory syncytial virus (RSV) in adults, CDC vaccination recommendations, and the role of immunization in protecting vulnerable populations. Sessions will be offered throughout August and September. Learn more about the upcoming sessions and register for your desired date.
MERCK | 2025 INFANT RSV IMMUNIZATION
Join Merck for an informative and engaging 60-minute webinar delving into the impact of RSV on neonates and infants. Gain the latest insights on disease prevention and learn about current vaccine advancements from leading experts. Sessions available August 20 and September 16. Register for the session that works best for you.
MODERNA | COVID-19 AND RSV VACCINE UPDATES
Get up to speed on Moderna’s latest COVID-19 and RSV vaccine data. This webinar will cover recent clinical insights and medical updates relevant to providers. Join live on September 18 at 2 PM EDT.
PFIZER | UPDATED COVID-19 VACCINES TRAINING SERIES
Co-hosted with BioNTech, this training is tailored for U.S. healthcare providers and immunization staff. Topics include the 2025-2026 formula characteristics, storage and handling, and preparation and dosing details. Multiple sessions offered in August and September. Register for your preferred session.
SANOFI | CODING, COVERAGE, AND REIMBURSEMENT
Prepare for the upcoming respiratory illness season with practical guidance on coding, billing, and reimbursement for Sanofi’s flu, COVID-19, and RSV vaccines. Sessions will be held October 2. Pre-registration is required, sign up here.
The Seasonal ‘Tripledemic’
Since the onset of the COVID-19 pandemic, there has been a concurrent surge in three respiratory diseases, coined the ‘tripledemic’: influenza (flu), respiratory syncytial virus (RSV), and COVID-19. During the 2022–2023 respiratory virus season, these three diseases infected millions of people across the United States, resulting in more than 100,000 deaths over four months. The increased rates of hospitalization placed a strain on already overwhelmed healthcare institutions and professionals and minimized available resources.
To mitigate this strain and reduce the disease burden, it is essential that at-risk populations are up to date with their recommended vaccines ahead of the winter months. To help protect your patients against the tripledemic, we have compiled a list of our seasonal vaccine offerings as well as the vaccine recommendations issued by the US Centers for Disease Control and Prevention (CDC).
Flu Vaccines
The CDC recommends that all patients receive their flu vaccine by the end of October to activate herd immunity before peak flu activity, December through February, and to ensure that patients receive the vaccine’s full benefits throughout the season.
Manufacturers
Vaccine Offerings
Afluria (Standard)
FluLaval/Fluarix (Standard)
Fluzone (Standard)
Flublok (Enhanced Dose)
Fluzone HD (High Dose)
Flumist (Nasal)
Fluad (Adjuvant)
Flucelvax (Cell Based)
RSV Vaccines
The CDC recommends that adults over 60 years of age be vaccinated against RSV, using shared clinical decision making. To protect infants, it is recommended that pregnant patients receive the vaccine between 32 and 36 weeks’ gestation. The CDC recommends that infants whose mothers were not vaccinated during pregnancy receive the vaccine upon birth.
Manufacturers
Vaccine Offerings
Abrysvo (Adults 60+ and Pregnant Patients)
Arexvy (Adults 60+)
Beyfortus (Infants)
Enflonsia (Infants)
Manufacturers
Vaccine Offerings
Comirnaty
Nuvaxovid
Spikevax
Atlantic Health Partners is the leading resource for physicians, practices, and clinics to help immunize their patients against RSV, COVID-19, and the flu. By becoming a member, you will secure favorable vaccine pricing, better payment terms, overnight delivery, and comprehensive support for all immunization-related issues.
Interested in vaccine procurement or learning more about our membership program?